Follow the latest in biotechnology, gene therapy developments, and life sciences research. From CRISPR advances to clinical breakthroughs.
Curated AI briefing - Updates with new content
AI Learns to Predict Breast Cancer Risk from How Single Cells Respond to Pressure Genetic Engineering and Biotechnology News Headshot of researchers (IMAGE) EurekAlert! AI squeezes individual breast cells to learn how to spot cancer risk Medical Xpress City of Hope and UC Berkeley Researchers Teach AI to Spot Cancer Risk by Squeezing Individual...
Researchers created a novel microfluidic platform, AI tool, and risk score that can assess women’s breast cancer risk at the cellular level, based on the how how breast cancer cells respond to being squeezed, and their “mechanical age.” The post AI Learns to Predict Breast Cancer Risk from How Single Cells Respond to Pressure appeared first on...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming...
Paterna Biosciences said it has mastered the molecular signals that teach stem cells how to mature into sperm for a promising new fertility treatment.
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
NEWYou can now listen to Fox News articles! A new therapy for genetic hearing loss has just been approved by [...]
As China pours billions into biotech, a new analysis argues U.S. leadership will hinge on state-level tax credits, training programs and public-private partnerships.
CEO Jason Kelly of Ginkgo Bioworks, left, shows Energy Secretary Chris Wright the new Anaerobic Microbial Phenotyping Platform, known as AMP2, on the Pacific Northwest National Laboratory campus in Richland. The platform, which integrates autonomous experimental hardware with AI-guided software to speed biotechnology discovery, will be used in...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both pediatric and adult patients after positive results.
TUCSON, AZ / ACCESS Newswire / April 23, 2026 / WEED Inc. (OTCQB:BUDZ) ("BUDZ" or the "Company"), a cannabis bioresearch and genetics-focused public company, today issued a strategic corporate update following the U.S. Department of Justice and Drug Enforcement Administration announcement placing FDA-approved marijuana products and marijuana...
The Department of Justice's Office of the Inspector General announced Thursday that it would do an audit of the release of the Epstein files.
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, May 6 to provide a corporate update and discuss its financial results for the first quarter ended March 31, 2026. The conference call may be accessed on the Events &...
The Oregon Ducks will see some of their former players take one more step towards their dream in the first round of the NFL Draft on Thursday.
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Excessive Daytime Sleepiness pipeline constitutes 10+ key companies continuously working towards developing 12+ Excessive Daytime Sleepiness treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration,
Ayatollah Mojtaba Khamenei Surrounded By 24/7 Medical Team In Hideout As Generals Run Iran: NYT The NY Times in a new deep dive of what governing structures now look like inside Iran says what's already long been obvious to many in the wake of longtime Ayatollah Ali Khamenei's death: "When Ayatollah Ali Khamenei ruled Iran as the supreme...
Market Summary As per Data Bridge Market Research analysis, the Regenerative Medicine Market was estimated at USD 42.48 billion in 2025. The market is expected to grow from USD 50.90 billion in 2026 to USD 180.15 billion in 2033, at a
[»] Jump to Summary... A fresh push to connect Nigerian ideas with real-world business value is gaining momentum as the Federal Ministry of Innovation, Science and Technology (FMIST), led by Dr. Kingsley Tochukwu Udeh, SAN, announces a major collaboration with the Kano State Government and other partners ahead of the launch of the Energise...
More than two in five U.S. adults has prediabetes, a condition marked by higher-than-normal blood sugar levels that often leads to type 2 diabetes.
AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- In an era where marketing teams are under increasing pressure to prove real business impact with volume-driven metrics and inconsistent lead quality, Vereigen Media, a leading U.S.-based B2B demand generation company, today announced the launch of its Revenue-First Demand Generation Programs....
/CNW/ - The Honourable Sean Fraser, Minister of Justice and Attorney General of Canada and Minister responsible for the Atlantic Canada Opportunities Agency,...
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals Inc.’s DB-OTO, an AAV-mediated gene therapy. Branded Otarmeni (lunsotogene parvec), it is cleared specifically for hearing loss caused by variants in the otoferlin gene.
The radiosurgery and radiotherapy robotics sector is poised for significant expansion as technological advances and increasing healthcare demands drive the market forward. With innovations enhancing treatment precision and personalized care, the industry is set to grow substantially over the next
Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how advancing drug pipelines are reshaping biotech valuations, as scientific progress is increasingly recognized as a measurable financial asset under evolving accounting frameworks. The piece highlights Oncotelic’s position at the intersection of...
The latest release extends HemaConnect — the blood and plasma industry's leading donor engagement solution — to enable efficient recruitment, scheduling, and tracking of donors for highly specialized, life‐saving therapies. BALTIMORE, April 23, 2026 /PRNewswire/ -- InVita Healthcare...
International study demonstrates promising clinical activity of pembrolizumab plus lenvatinib in recurrent disease, addressing a longstanding treatment gap SINGAPORE, April 23, 2026 /PRNewswire/ -- Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in...
WFA has signed strategic partnership agreements with two leading educational establishments in Asia Pacific to promote marketing to the new generation in the region. To ensure that the marketers of tomorrow are equipped with the right skillset to champion better marketing, WFA is bringing Asia’s leading CMOs into classrooms. The focus: to show...
Create your own AI-powered briefing on any topic — delivered automatically.
You might also enjoy these briefings
Follow OpenAI, Google AI, and AWS platform news. Track API updates, model...
Daily briefing on medical research news, treatment breakthroughs, and...
Stay ahead of the curve with our AI & Digital Transformation newsletter! ...
Track FDA drug approvals, clinical trial results, and pharmaceutical...
Enjoyed this briefing? Get it delivered to your inbox!
Create Free Account
